Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Kiyomitsu, Miyachi"'
Autor:
Akiko Ihara, Kiyomitsu Miyachi
Publikováno v:
Nihon Naika Gakkai Zasshi. 108:2107-2115
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1e5c6f030d4db2c61c1c8f9eb1912823
https://doi.org/10.2169/naika.108.2107
https://doi.org/10.2169/naika.108.2107
Autor:
Shinichi Mashiba, Toshiko Igarashi, So Nomoto, Koyama Takao, Belinda Sasse, Kiyomitsu Miyachi
Publikováno v:
American Journal of Biomedical Science & Research. 1:124-129
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9773fd0628c24901babc425ea1f6b77a
https://doi.org/10.34297/ajbsr.2019.01.000525
https://doi.org/10.34297/ajbsr.2019.01.000525
Autor:
Jordi Carratalà, Keijiro Saku, Toshitsugu Ishikawa, Akihiro Inazu, Kiyomitsu Miyachi, Mancho N, Katsuhiko Mikoshiba, Minoru Ihara, Toshiko Igarashi, Belinda Sasse, Takao Koyama
Publikováno v:
Biomedical Journal of Scientific & Technical Research. 9
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ee3cbb92b3ec1db54efeb4afc6c0f39f
https://doi.org/10.26717/bjstr.2018.09.001868
https://doi.org/10.26717/bjstr.2018.09.001868
Publikováno v:
Autoimmunity Reviews. 11:771-775
Autoantibodies targeting the proliferating cell nuclear antigen (PCNA) were first described over 30 years ago and are historically most commonly associated with systemic lupus erythematosus (SLE). The primary antigenic target is a 34 kDa protein that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea23c7c8525cbd434b899201ef3b8f1f
https://doi.org/10.1016/j.autrev.2012.02.012
https://doi.org/10.1016/j.autrev.2012.02.012
Autor:
Kiyomitsu Miyachi, Akihiro Mizutani, Akira Futatsugi, Chihiro Hisatsune, Takeshi Nakamura, Katsuhiko Mikoshiba
Publikováno v:
Cornea. 27:S3-S8
Inositol 1,4,5-trisphosphate (IP3) is a second messenger that induces the release of calcium from the endoplasmic reticulum (ER). The IP3 receptor was discovered as a developmentally regulated glycophosphoprotein, P400, that is absent in strains of m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22300f08993e5d4aa7c7d66bd5764a29
https://doi.org/10.1097/ico.0b013e31817f246e
https://doi.org/10.1097/ico.0b013e31817f246e
Autor:
Mittermayer Barreto Santiago, M. Khraishi, Kiyomitsu Miyachi, Suzanne S. Taillefer, Maysan Abu-Hakima, Mary J. Bell, David Robinson, Niall Jones, Murray Baron, Marie Hudson, Peter Docherty, Janet Markland, E. Sutton, Janet E. Pope, Sharon LeClercq, Denise L. Smith, Marvin J. Fritzler, Jean-Pierre Mathieu
Publikováno v:
Clinical Rheumatology. 27:77-83
The objective was to investigate the frequency of anti-cyclic citrullinated peptides (CCP) antibodies in systemic sclerosis (SSc) and primary biliary cirrhosis (PBC), utilizing a new "third generation" anti-CCP ELISA (anti-CCP3) kit and a conventiona
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::727c11bf169e9b8cc47a600598d58c2e
https://doi.org/10.1007/s10067-007-0656-4
https://doi.org/10.1007/s10067-007-0656-4
Autor:
Miwako Iwai, Kiyomitsu Miyachi, Raleigh W. Hankins, Tetsuroh Okano, Katsuhiko Mikoshiba, Minoru Ihara, Marvin J. Fritzler, Akira Miyamoto
Publikováno v:
Clinical Rheumatology. 26:1571-1574
In this report, we present a 63-year-old woman who had limited cutaneous systemic sclerosis and subsequently developed typical primary biliary cirrhosis after an acute myocardial infarction. The patient initially developed Raynaud's phenomenon, and 4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d2a7efa2c66ff41b9c67647c6172f01
https://doi.org/10.1007/s10067-006-0465-1
https://doi.org/10.1007/s10067-006-0465-1
Autor:
Takeshi Shigematsu, Ietaka Satoh, Kiyomitsu Miyachi, Tetsunari Maeda, Seizaburo Kashiwagi, Hideyuki Ikematsu, Naoki Kawai, Nobuo Hirotsu, Takashi Kawashima, Norio Iwaki
Publikováno v:
Clinical Infectious Diseases. 40:1309-1316
Background To evaluate the effectiveness of oseltamivir and amantadine for the treatment of influenza with respect to various clinical factors, a prospective multicenter study of the influenza season of 2002-2003 was done with 2163 patients whose con
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81f9e33cffce1eeb1e741d54253e7ca4
https://doi.org/10.1086/429241
https://doi.org/10.1086/429241
Publikováno v:
Clinical Rheumatology. 22:329-332
We report on an 80-year-old man with rheumatoid arthritis (RA) who presented with chronic myelogenous leukemia (CML). Five years after the onset of RA, the CML diagnosis was made. The patient was treated for CML with 300 mg of imatinib mesylate (STI;
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50a46b8a9bc374c7422126ebb7bc754c
https://doi.org/10.1007/s10067-003-0716-3
https://doi.org/10.1007/s10067-003-0716-3
Autor:
Sadaki Yokota, Akira Inomata, Mizuho Kaneda, Tsuneyoshi Horigome, Tomoaki Nakagawa, Masato Umeda, Kiyomitsu Miyachi, Saburo Omata, Kazuhiro Furukawa, Yasuhiro Hirano
Publikováno v:
Journal of Biological Chemistry. 278:20395-20404
We found an autoimmune serum, K199, that strongly suppresses nuclear membrane assembly in a cell-free system involving a Xenopus egg extract. Four different antibodies that suppress nuclear assembly were affinity-purified from the serum using Xenopus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b941c9537944b1dc2b54204d630bffa
https://doi.org/10.1074/jbc.m210824200
https://doi.org/10.1074/jbc.m210824200